The National Medicines Regulatory Authority (NMRA) is considering increasing the prices of certain medicines following the depreciation of the Sri Lankan rupee against the US dollar.
NMRA Chairman Specialist Dr. Ananda Wijewickrama said the necessary procedures are currently underway, with initial steps already taken to review the prices of imported medicines as well as locally manufactured pharmaceutical products.
He noted that price revisions are also being considered for 60 categories of medicines whose maximum retail prices are regulated through gazette notifications.
Dr. Wijewickrama explained that the weakening of the rupee has driven up costs across multiple sectors, including the pharmaceutical industry, prompting authorities to assess the impact on medicine prices. While not all medicines will be affected, he said some categories are likely to experience price increases due to higher import and production costs.
